全文获取类型
收费全文 | 196820篇 |
免费 | 17093篇 |
国内免费 | 8267篇 |
专业分类
耳鼻咽喉 | 2406篇 |
儿科学 | 4435篇 |
妇产科学 | 2211篇 |
基础医学 | 34086篇 |
口腔科学 | 5497篇 |
临床医学 | 17005篇 |
内科学 | 26629篇 |
皮肤病学 | 4564篇 |
神经病学 | 10610篇 |
特种医学 | 4559篇 |
外国民族医学 | 118篇 |
外科学 | 17383篇 |
综合类 | 30945篇 |
现状与发展 | 48篇 |
预防医学 | 7769篇 |
眼科学 | 3596篇 |
药学 | 15906篇 |
44篇 | |
中国医学 | 6815篇 |
肿瘤学 | 27554篇 |
出版年
2024年 | 404篇 |
2023年 | 2739篇 |
2022年 | 4938篇 |
2021年 | 7024篇 |
2020年 | 6238篇 |
2019年 | 5851篇 |
2018年 | 6061篇 |
2017年 | 6403篇 |
2016年 | 6771篇 |
2015年 | 7642篇 |
2014年 | 11788篇 |
2013年 | 12857篇 |
2012年 | 11245篇 |
2011年 | 12511篇 |
2010年 | 10293篇 |
2009年 | 9859篇 |
2008年 | 10239篇 |
2007年 | 10409篇 |
2006年 | 9546篇 |
2005年 | 8636篇 |
2004年 | 7637篇 |
2003年 | 6632篇 |
2002年 | 5485篇 |
2001年 | 4723篇 |
2000年 | 4012篇 |
1999年 | 3558篇 |
1998年 | 3322篇 |
1997年 | 3065篇 |
1996年 | 2732篇 |
1995年 | 2427篇 |
1994年 | 2152篇 |
1993年 | 1826篇 |
1992年 | 1492篇 |
1991年 | 1394篇 |
1990年 | 1110篇 |
1989年 | 1014篇 |
1988年 | 992篇 |
1987年 | 811篇 |
1986年 | 727篇 |
1985年 | 939篇 |
1984年 | 886篇 |
1983年 | 598篇 |
1982年 | 655篇 |
1981年 | 534篇 |
1980年 | 468篇 |
1979年 | 354篇 |
1978年 | 275篇 |
1977年 | 223篇 |
1976年 | 165篇 |
1973年 | 115篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
91.
《Transfusion and apheresis science》2020,59(4):102855
The activation of the innate and adaptive immune systems by SARS-CoV-2 causes the release of several inflammatory cytokines, including IL-6. The inflammatory hypercytokinemia causes immunopathological changes in the lungs including vascular leakage, and alveolar edema. As a result of these changes in the lungs, hypoxia and acute respiratory distress syndrome occur in patients with COVID-19. Even though there are clinical trials on the development of therapeutics and vaccines, there are currently no licensed vaccines or therapeutics for COVID-19. Pharmacological approaches have shown poor results in sepsis-like syndromes caused by the hypercytokinemia. Suppressing the cytokine storm is an important way to prevent the organ damage in patients with COVID-19. Extracorporeal blood purification could be proposed as an adjunctive therapy for sepsis, aiming to control the associated dysregulation of the immune system, which is known to protect organ functions. Several extracorporeal blood purification therapies are now available, and most of them target endotoxins and/or the cytokines and aim improving the immune response. For this purpose, plasmapheresis and immunoadsorption may be an important adjunctive treatment option to manage the complications caused by cytokine storm in critically ill patients with COVID-19. 相似文献
92.
张献彩 《山西医科大学学报》2015,(1)
目的:观察糖尿病小鼠小肠绒毛杯状细胞分泌的黏原颗粒是否改变,为进一步研究糖尿病的消化系统并发症提供形态学基础。方法分别选取3,5,8,10月龄db/db糖尿病小鼠及相应年龄段的db/+m正常小鼠,每组6只,标本用4%多聚甲醛灌流固定后,从距Treitz韧带约10 cm处切下一段空肠,用PAS染色方法对小肠杯状细胞分泌的黏原颗粒进行观察。结果糖尿病组小肠绒毛易被破坏,糖尿病组中杯状细胞的分泌物比同月份正常对照组显著增加(P<0.05);糖尿病组中3月龄的杯状细胞分泌物最多,8月龄最少,并且8月龄分别与3月龄、5月龄比较均存在着显著差异(P<0.05);正常对照组随月龄增长无显著性差异(P>0.05)。结论糖尿病时杯状细胞分泌物增多可能对小肠绒毛有保护作用。 相似文献
93.
《Cancer cell》2021,39(11):1497-1518.e11
- Download : Download high-res image (282KB)
- Download : Download full-size image
94.
《Revista espa?ola de anestesiología y reanimación》2022,69(9):517-525
Background and objectivesThe ideal timing of tranexamic acid administration in total knee arthroplasty with tourniquet remains unclear. Our primary objective was to prove if administering it before surgical incision, instead of before releasing the tourniquet, reduces postoperative bleeding. A second objective was to determine whether a second dose reduces post-operative bleeding.Material and methodsA prospective, double-blind clinical trial was performed on 212 patients scheduled for total knee arthroplasty. They were randomised into 4 groups. Tranexamic acid was administered before the surgical incision in “pre-induction groups” (1 and 2), and just before the tourniquet release in “pre-release groups” (3 and 4). Groups 2 and 4 received a second dose 3 hours post-surgery. Main outcome was postoperative bleeding (visible blood loss and calculated total bleeding). Secondary outcomes were haemoglobin variations, complications and transfusion rate.ResultsThe mean calculated total bleeding was 1563 ml (95%CI: 1445 to 1681) in preinduction groups versus 1576 ml (95%CI: 1439 to 1713) in pre-release groups (P = .9); 1579 ml (95%CI: 1452 to 1706) in single-dose groups versus 1559 ml (95%CI: 1431 to 1686) in double-dose groups (P = .82). One patient was transfused. The mean haemoglobin at discharge was 10.4 g/dl (95%CI: 10.2 to 10.7) in singledose groups versus 10.8 (95%CI: 10.6 to 11.1) in double-dose groups (P = .06).ConclusionsThere were no differences in bleeding or transfusion regarding the time of tranexamic acid administration. The second dose had not impact on outcomes.Trial registration: EudraCT 2016-000071-24. 相似文献
95.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。 相似文献
96.
97.
98.
《Vaccine》2016,34(24):2663-2670
Human metapneumovirus (HMPV) is a major cause of morbidity and mortality from acute lower respiratory tract illness, with most individuals seropositive by age five. Despite the presence of neutralizing antibodies, secondary infections are common and can be severe in young, elderly, and immunocompromised persons. Preclinical vaccine studies for HMPV have suggested a need for a balanced antibody and T cell immune response to enhance protection and avoid lung immunopathology. We infected transgenic mice expressing human HLA-A*0201 with HMPV and used ELISPOT to screen overlapping and predicted epitope peptides. We identified six novel HLA-A2 restricted CD8+ T cell (TCD8) epitopes, with M39–47 (M39) immunodominant. Tetramer staining detected M39-specific TCD8 in lungs and spleen of HMPV-immune mice. Immunization with adjuvant-formulated M39 peptide reduced lung virus titers upon challenge. Finally, we show that TCD8 from HLA-A*0201 positive humans recognize M39 by IFNγ ELISPOT and tetramer staining. These results will facilitate HMPV vaccine development and human studies. 相似文献
99.
糖尿病已成为全球威胁人类健康的三大慢性非传染性疾病之一。需要外科手术的患者占所有糖尿病患者的25%,其围手术期病死率、并发症以及住院时间较正常人明显增加,因此对于糖尿病患者围手术期的处理方案显得尤为重要。但目前对于围手术期血糖控制范围仍众说纷纭,综合各研究结论,笔者认为将血糖控制在7.8~10 mmol/L是一个较为理想的范围。在患者术前、术中及术后应联合多学科制定各项相应的治疗方案,围手术期尤为注意避免患者发生低血糖和电解质紊乱的发生。也亟待后续大规模的随机对照试验进一步确定有效的血糖控制目标。 相似文献
100.
《Molecular therapy》2020,28(6):1432-1441
- Download : Download high-res image (155KB)
- Download : Download full-size image